Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 42, Issue 2, 2013, Pages 154-161

  Geomela, Panagiota Aikaterini ^a   Kontos, Christos K ^a   Yiotakis, Ioannis ^a   Scorilas, Andreas ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

BCL2 family; Larynx; Oral cancer; Tongue; Tumor biomarkers

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA;

ADVANCED CANCER; APOPTOSIS; ARTICLE; BCL2L12 GENE; BUCCAL MUCOSA CARCINOMA; GENE; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; NASOPHARYNX CARCINOMA; NOSE CAVITY CANCER; NUCLEOTIDE SEQUENCE; PAROTID GLAND CARCINOMA; PHARYNX CARCINOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TONGUE CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; MUSCLE PROTEINS; NASAL CAVITY; NEOPLASM GRADING; NEOPLASM STAGING; NOSE NEOPLASMS; PAROTID NEOPLASMS; PHARYNGEAL NEOPLASMS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84873258684     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2012.01190.x     Document Type: Article

References (57)

1. Chin D, Boyle GM, Porceddu S, et al.Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 2006; 6: 1111-8.
2. Perez-Ordonez B, Beauchemin M, Jordan RC. Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 2006; 59: 445-53.
3. Argiris A, Karamouzis MV, Raben D, et al.Head and neck cancer. Lancet 2008; 371: 1695-709.
4. Patel SG, Shah JP. TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 2005; 55: 242-58; quiz 261-2, 264.
5. Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2003; 260: 502-8.
6. Lothaire P, De Azambuja E, Dequanter D, et al.Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation. Head Neck 2006; 28: 256-69.
7. Sotiriou C, Lothaire P, Dequanter D, et al.Molecular profiling of head and neck tumors. Curr Opin Oncol 2004; 16: 211-4.
8. Rodrigo JP, Ferlito A, Suarez C, et al.New molecular diagnostic methods in head and neck cancer. Head Neck 2005; 27: 995-1003.
9. Scorilas A, Kyriakopoulou L, Yousef GM, et al.Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family. Genomics 2001; 72: 217-21.
10. Kontos CK, Scorilas A. Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells. Gene 2012; doi:10.1016/j.gene.2012.04.084.
11. Mathioudaki K, Scorilas A, Papadokostopoulou A, et al.Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer. Biol Chem 2004; 385: 779-83.
12. Kontos CK, Papadopoulos IN, Scorilas A. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer. Biol Chem 2008; 389: 1467-75.
13. Talieri M, Diamandis EP, Katsaros N, et al.Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors. Thromb Haemost 2003; 89: 1081-8.
14. Thomadaki H, Talieri M, Scorilas A. Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer. Cancer Lett 2007; 247: 48-55.
15. Florou D, Papadopoulos IN, Scorilas A. Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer. Biochem Biophys Res Commun 2010; 391: 214-8.
16. Stegh AH, Kim H, Bachoo RM, et al.Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma. Genes Dev 2007; 21: 98-111.
17. Fendri A, Kontos CK, Khabir A, et al.BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma. Mol Med 2011; 17: 163-71.
18. Papageorgiou SG, Kontos CK, Pappa V, et al.The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker. Oncologist 2011; 16: 1280-91.
19. Thomadaki H, Floros KV, Pavlovic S, et al.Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia. Clin Biochem 2012; doi:10.1016/j.clinbiochem.2012.06.012.
20. Kontos CK, Papadopoulos IN, Fragoulis EG, et al.Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma. Br J Cancer 2010; 102: 1384-90.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8.
22. Burbelo P, Bayat A, Lebovitz E, et al.New technologies for studying the complexity of oral diseases. Oral Dis 2012; 18: 121-6.
23. Murugan AK, Munirajan AK, Tsuchida N. Ras oncogenes in oral cancer: The past 20years. Oral Oncol 2012; 48: 383-92.
24. Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993; 53: 3579-84.
25. Szabo B, Nelhubel GA, Karpati A, et al.Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas. Oral Oncol 2011; 47: 487-96.
26. Maurizi M, Almadori G, Ferrandina G, et al.Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 1996; 74: 1253-7.
27. Chung CH, Ely K, Mcgavran L, et al.Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol 2006; 24: 4170-6.
28. Nimeus E, Baldetorp B, Bendahl PO, et al.Amplification of the cyclin D1 gene is associated with tumour subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck. Oral Oncol 2004; 40: 624-9.
29. Bellacosa A, Almadori G, Cavallo S, et al.Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin Cancer Res 1996; 2: 175-80.
30. Dong Y, Sui L, Sugimoto K, et al.Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas. Int J Cancer 2001; 95: 209-15.
31. Dong Y, Sui L, Tai Y, et al.The overexpression of cyclin-dependent kinase (CDK) 2 in laryngeal squamous cell carcinomas. Anticancer Res 2001; 21: 103-8.
32. Tamura N, Dong Y, Sui L, et al.Cyclin-dependent kinase inhibitor p27 is related to cell proliferation and prognosis in laryngeal squamous cell carcinomas. J Laryngol Otol 2001; 115: 400-6.
33. Bazan V, Zanna I, Migliavacca M, et al.Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma. J Cell Physiol 2002; 192: 286-93.
34. Friedman M, Grey P, Venkatesan TK, et al.Prognostic significance of Bcl-2 expression in localized squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol 1997; 106: 445-50.
35. Gallo O, Bianchi S, Porfirio B. Bcl-2 overexpression and smoking history in head and neck cancer. J Natl Cancer Inst 1995; 87: 1024-5.
36. De Vicente JC, Olay S, Lequerica-Fernandez P, et al.Expression of Bcl-2 but not Bax has a prognostic significance in tongue carcinoma. J Oral Pathol Med 2006; 35: 140-5.
37. Fendri A, Kontos CK, Khabir A, et al.Quantitative analysis of BCL2 mRNA expression in nasopharyngeal carcinoma: an unfavorable and independent prognostic factor. Tumour Biol 2010; 31: 391-9.
38. Chen MK, Lai JC, Chang CC, et al.Prognostic impact of bcl-2 expression on advanced nasopharyngeal carcinoma. Head Neck 2008; 30: 1052-7.
39. Chen MK, Yang SF, Lai JC, et al.Expression of bcl-2 correlates with poor prognosis and modulates migration of nasopharyngeal carcinoma cells. Clin Chim Acta 2010; 411: 400-5.
40. Nichols AC, Finkelstein DM, Faquin WC, et al.Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer. Clin Cancer Res 2010; 16: 2138-46.
41. Michaud WA, Nichols AC, Mroz EA, et al.Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma. Clin Cancer Res 2009; 15: 1645-54.
42. Hammond PW, Alpin J, Rise CE, et al.In vitro selection and characterization of Bcl-X(L)-binding proteins from a mix of tissue-specific mRNA display libraries. J Biol Chem 2001; 276: 20898-906.
43. Stegh AH, Kesari S, Mahoney JE, et al.Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma. Proc Natl Acad Sci USA 2008; 105: 10703-8.
44. Stegh AH, Chin L, Louis DN, et al.What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional cell death regulatorCell Cycle 2008; 7: 2833-9.
45. Stegh AH, Brennan C, Mahoney JA, et al.Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor. Genes Dev 2010; 24: 2194-204.
46. Piccirillo JF, Lacy PD, Basu A, et al.Development of a new head and neck cancer-specific comorbidity index. Arch Otolaryngol Head Neck Surg 2002; 128: 1172-9.
47. Nguyen-Tan PF, Le QT, Quivey JM, et al.Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience. Int J Radiat Oncol Biol Phys 2001; 50: 1172-80.
48. Assimakopoulos D, Kolettas E, Zagorianakou N, et al.Prognostic significance of p53 in the cancer of the larynx. Anticancer Res 2000; 20: 3555-64.
49. Nadal A, Campo E, Pinto J, et al.p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors. J Pathol 1995; 175: 181-8.
50. Nylander K, Dabelsteen E, Hall PA. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 2000; 29: 413-25.
51. Schmitt E, Paquet C, Beauchemin M, et al.Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation. Oncogene 2004; 23: 3915-31.
52. Kearsley JH, Thomas S. Prognostic markers in cancers of the head and neck region. Anticancer Drugs 1993; 4: 419-29.
53. Kurokawa H, Zhang M, Matsumoto S, et al.The high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma. J Oral Pathol Med 2005; 34: 329-33.
54. Odell EW, Jani P, Sherriff M, et al.The prognostic value of individual histologic grading parameters in small lingual squamous cell carcinomas. The importance of the pattern of invasion. Cancer 1994; 74: 789-94.
55. Kademani D, Bell RB, Bagheri S, et al.Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. J Oral Maxillofac Surg 2005; 63: 1599-605.
56. Rusthoven K, Ballonoff A, Raben D, et al.Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma. Cancer 2008; 112: 345-51.
57. Drucker KL, Kitange GJ, Kollmeyer TM, et al.Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell-mediated restoration of normal human chromosome 19. Genes Chromosom Cancer 2009; 48: 854-64.